Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mohammad A. Chaudhary
Cost-Effectiveness of Infliximab for the Treatment of Acute Exacerbations of Ulcerative Colitis in the Netherlands
Biologics in Therapy
Related publications
Cost-Minimization Analysis of Infliximab Versus Adalimumab in the Treatment of Crohn’s Disease and Ulcerative Colitis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Utility Analysis of Infliximab and Adalimumab for Refractory Ulcerative Colitis
Cost Effectiveness and Resource Allocation
Health Policy
Cost-Effectiveness of Early Assisted Discharge for COPD Exacerbations in the Netherlands
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Has Infliximab Influenced the Course and Prognosis of Acute Severe Ulcerative Colitis?
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Letter: Dose Optimising Infliximab in Acute Severe Ulcerative Colitis
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Psy100 - Cost-Effectiveness Analysis of Second Line Treatment for Patients With Ulcerative Colitis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Letter: Should We Intensify Infliximab in Acute Severe Ulcerative Colitis?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Golimumab for the Treatment of Ulcerative Colitis
Expert Opinion on Biological Therapy
Drug Discovery
Clinical Biochemistry
Pharmacology
A Type II Segmental Vitiligo Developed Under Infliximab Treatment for Ulcerative Colitis
Annals of Dermatology
Dermatology
